18 Jun 2026
Gibson Dunn Adds Margaux J. Hall to Strengthen Drug Pricing and Market Access Practice
"Gibson Dunn welcomes partner Margaux J. Hall to its FDA and Health Care and Life Sciences Practice in Washington, D.C., where she will advise on drug pricing, market access and value‑based arrangements."
Margaux is a leading health regulatory lawyer who advises pharmaceutical manufacturers, investors, and other entities in the supply chain on drug pricing, market access, and value‑based arrangements. She will join Gibson Dunn at partner level in the firm’s FDA and Health Care and Life Sciences Practice Groups.
Margaux’s practice focuses on the legal and policy changes affecting pricing, reimbursement, coverage, and access to drugs, vaccines, and devices, and she regularly provides health regulatory counsel on mergers and other transactions, as well as government enforcement and litigation matters. She has pursued a Fulbright Program fellowship to research health care law and health system reform in South Africa and led related research programs at the World Bank Group. Prior to joining Gibson Dunn, Margaux was a partner at an international law firm.